– AliveCor, a leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal ECG system, the AI-powered KardiaMobile® 6L Max. – ...

WELL Health and AliveCor have partnered to bring rapid, cardiologist-reviewed ECG services to patients across Canada through the Kardia platform. Under this partnership, WELL Health's ...

KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews. KardiaAlert is a ...

The AliveCor monitor is in a thin case with two electrodes that snaps onto the back of an iPhone 4 or 5. To obtain an ECG recording, the patient just holds the device while pressing fingers from each ...

Japan-based medical device company Omron Healthcare has partnered with AliveCor to help bring AliveCor's FDA-cleared smartphone-connected electrocardiogram (ECG) to more online and brick and mortar ...

The seeds of the dispute were sown back in 2016, when AliveCor unveiled a watchband and connected app for the Apple Watch that would allow wearers to take ECG readings at any time. The KardiaBand was ...

Collaboration brings the next generation of cutting-edge ECG technology to trial participants' homes, enabling accurate cardiac safety trial measurements with fewer site visits. Clario and AliveCor ...

Page Report Maps Patch, Smartwatch, and Handheld ECG Devices as Regulatory Clearances and AI-Powered Arrhythmia Detection Reshape Cardiac Monitoring Outside the ClinicDublin, Sept. 04, 2026 (GLOBE ...

San Francisco-based AliveCor has inked a deal with electronic medical records company Practice Fusion that enables healthcare providers who use AliveCor's smartphone-enabled, single-channel ECG to ...

Mobile health pioneer AliveCor has debuted its third-generation heart monitor, which is now available for $74.99. That price point is a considerably lower than that of the $199 price tag of earlier ...

AliveCor Inc. has announced publication of the results of its Search-AF trial, which used the AliveCor Heart Monitor to screen 1000 pharmacy customers over the age of 65 for atrial fibrillation (AF), ...